Published

Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of analytical toxicology
Date: 2007-10-01
Source: PubMed
DOI: 10.1093/jat/31.8.497
PubMed: 17988464

Authors

del Mar Ramirez Fernandez M Laloup M Wood M De Boeck G Lopez-Rivadulla M Wallemacq P Samyn N

Watch author

Derived topics and classifications

psilocin General Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 7 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Quantification of psilocin in human whole blood using liquid chromatography-tandem mass spectrometry (LC-MS/MS)2024-03-01 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry2024-03-01 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01 Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis2020-03-29 Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS2013-05-01 A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability2012-11-01 Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.2007-10-01

Related papers

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging StudyClinicalTrials.gov · 2025-08-20 Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17 Maddening Therapies: How Hallucinogens Morphed into Novel TreatmentsCurrent psychiatry · 2017-01-01 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20